TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Four cancer centers form privately-funded Multiple Myeloma Research Consortium. Plan grew out of a recommendation to NCI, but organizers didn’t want to wait for the government to take action. September 10, 2004
